Clinical Trials Browser

Ureteral Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00749892 2020-09-10

Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer

Phase 2 Completed

34 enrolled 9 charts

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms